Evidence & regulatory context
- Mechanism
- Not recorded
- Target
- Not recorded
- Injury models
- Other
- Reported indication
- Not recorded
- First approval
- Not recorded
- Development stage
- Not recorded
- ChEMBL record
- Not recorded
- ChEMBL max phase
- Not recorded
- Synonyms
- Not recorded
- Note
- Not recorded
Clinical trials 0
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
No linked human trial in this dataset.
Preclinical evidence 1
1 studies reported at therapy level; 1 evidence entries itemised.
MixedOtherC57BL/6J wild typeNot stated for the ferric chloride thrombosis model; male and female used for pharmacokineticsn = 21 mice in the ferric chloride model (occlusion data from 7…Intravenous, 5 mL/kg into the right tail vein3 mg/kg (10 nmol/kg) intravenously for the thrombosis model…Injected intravenously 30 minutes before carotid injury; tail incision performe…
Model: Carotid artery exteriorised and injured by topical application of filter paper saturated with 15 per cent ferric chloride for 1 minute
Intravenous GPVI-CD39 at 3 mg/kg delayed carotid occlusion after ferric chloride injury from about 480 seconds to 1083 seconds, whereas vehicle and equimolar GPVI-Fc did not. Tail bleeding time was not prolonged at any dose, and ex vivo the fusion protein inhibited collagen, ADP and plaque-induced…
Extraction: extract · Supplied extraction confidence: 0.93. Machine-extracted fields require source verification.